Company Performance Metrics
Petrovax is a leading Russian company engaged in research, development and production of innovative pharmaceuticals. The company owns a portfolio of original products, including vaccines, immune system medicines and prolonged biotech drugs. The company operates a modern GMP-compliant facility in the Moscow Region with annual capacity in liquid
forms well above 150mn doses. Petrovax was one of the first Russian companies to receive a European GMP certificate and remains one of the few exporters of locally developed and produced drugs into the EU and the Middle East. Today Petrovax is the largest vaccines exporter in Russia. In 2020 Petrovax deeply engaged in COVID-19 Vaccine and Medication research and development, becoming the first Russian company to receive phase 3 clinical trial approvals for both.
